D
David C. Dale
Researcher at University of Washington
Publications - 419
Citations - 26111
David C. Dale is an academic researcher from University of Washington. The author has contributed to research in topics: Neutropenia & Congenital Neutropenia. The author has an hindex of 85, co-authored 406 publications receiving 24613 citations. Previous affiliations of David C. Dale include National Institutes of Health & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of colllection method, donor corticosteroid treatment, and short-term storage.
Thomas H. Price,David C. Dale +1 more
TL;DR: In vivo chemotactic ability of IFC neutrophils is slightly impaired, whereas that of FL cells is severely impaired; one-day storage of either cell concentrate causes further cell damage.
Journal ArticleDOI
The effect of cyclophosphamide on leukocyte kinetics and susceptibility to infection in patients with Wegener's granulomatosis.
TL;DR: In eight patients with Wegener's granulomatosis effective cyclophosphamide therapy significantly reduced blood neutrophil, monocyte, and lymphocyte counts; lymphocytes counts were most severely reduced.
Journal ArticleDOI
Gene Transfer in Baboons Using Prosthetic Vascular Grafts Seeded with Retrovirally Transduced Smooth Muscle Cells: A Model for Local and Systemic Gene Therapy
Randolph L. Geary,Alexander W. Clowes,Stella Lau,Selina Vergel,David C. Dale,William R. A. Osborne +5 more
TL;DR: Implantation of transduced cells within this type of vascular graft may provide a useful approach for long-term local and systemic gene therapy.
Journal ArticleDOI
Modulation of Neutrophil-Mediated Activity Against the Pseudohyphal Form of Candida albicans by Granulocyte Colony-Stimulating Factor (G-CSF) Administered In Vivo
TL;DR: It is demonstrated that G-CSF administered in vivo modulates PMNL-mediated fungicidal activity against the pseudohyphal form of C. albicans, thereby suggesting potential utility of G- CSF as a biologic response-modifying therapy in some opportunistic fungal infections.
Journal ArticleDOI
The rate of apoptosis in post mitotic neutrophil precursors of normal and neutropenic humans.
TL;DR: Using data on the fraction of post‐mitotic neutrophil precursors (CD15+ cells) displaying positive markers for apoptosis in 12 normal humans, and a simple mathematical model, the apoptotic rate is estimated to be about 0.28/day in this compartment, implying that the influx of myelocytes into the post-mitotic compartment exceeds twice the granulocyte turnover rate (GTR).